ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2026
Atrial fibrillation ablation using real-time three-dimensional transesophageal echocardiography as the primary intraprocedural imaging modality: a single-center feasibility study.
Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntracardiac echocardiography (ICE) is commonly used during atrial fibrillation (AF) ablation to facilitate transseptal access, catheter positioning, and intraprocedural safety monitoring but adds procedural cost and requires additional vascular access. Real-time three-dimensional transesophageal echocardiography (3D TEE) offers high-quality imaging without disposable intravascular catheters; however, its use as a primary intraprocedural imaging modality during contemporary AF ablation has been limited. This study evaluated the feasibility, safety, and procedural efficiency of using real-time 3D TEE in place of ICE for intraprocedural guidance during AF ablation.
methodsThis single-center feasibility study included 128 consecutive AF ablation procedures performed over an eight-month pilot period using real-time 3D TEE as the primary intraprocedural imaging modality. TEE was used for transseptal puncture guidance, catheter visualization, and intraprocedural safety monitoring. Procedural characteristics, fluoroscopy utilization, acute procedural success, complications, and same-day discharge rates were analyzed.
resultsAcute procedural ablation success was achieved in all cases. Procedures included de novo and repeat ablations, cases requiring lesion sets beyond pulmonary vein isolation, and concomitant left atrial appendage occlusion. No major acute complications, including pericardial effusion requiring intervention, clinically apparent esophageal injury, cerebrovascular events, or in-hospital mortality, were observed. Median total procedure time was 40 min (interquartile range (IQR) 32-50), median fluoroscopy time was 8.6 min (IQR 6.2-11.0), and median radiation dose was 39.1 mGy (IQR 23.2-78.9). Same-day discharge was achieved in 87.5% of procedures.
conclusionReal-time 3D TEE can be used as the primary intraprocedural imaging modality for AF ablation, providing effective guidance for transseptal access, catheter positioning, and safety monitoring without reliance on ICE. In centers with advanced echocardiographic expertise and appropriate training frameworks, this approach may represent a viable alternative to ICE with potential advantages in procedural workflow and resource utilization. Real-time three-dimensional transesophageal echocardiography can be used as the primary intraprocedural imaging modality during atrial fibrillation ablation, providing effective guidance for catheter manipulation and safety monitoring while avoiding disposable intracardiac echocardiography catheters and additional vascular access.
Indexed as
Identifiers
42166087What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.